- Home
- COCP vs COSM Comparison
COCP vs COSM Comparison
Compare COCP & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCP
- COSM
- Stock Information
- Founded
- COCP 2006
- COSM 2009
- Country
- COCP United States
- COSM United States
- Employees
- COCP N/A
- COSM N/A
- Industry
- COCP Biotechnology: Pharmaceutical Preparations
- COSM Other Pharmaceuticals
- Sector
- COCP Health Care
- COSM Health Care
- Exchange
- COCP Nasdaq
- COSM Nasdaq
- Market Cap
- COCP 15.7M
- COSM 12.9M
- IPO Year
- COCP N/A
- COSM 2013
- Fundamental
- Price
- COCP $1.49
- COSM $0.43
- Analyst Decision
- COCP Strong Buy
- COSM
- Analyst Count
- COCP 1
- COSM 0
- Target Price
- COCP $6.00
- COSM N/A
- AVG Volume (30 Days)
- COCP 26.0K
- COSM 190.3K
- Earning Date
- COCP 08-13-2025
- COSM 08-18-2025
- Dividend Yield
- COCP N/A
- COSM N/A
- EPS Growth
- COCP N/A
- COSM N/A
- EPS
- COCP N/A
- COSM N/A
- Revenue
- COCP N/A
- COSM $53,554,457.00
- Revenue This Year
- COCP N/A
- COSM $28.14
- Revenue Next Year
- COCP N/A
- COSM N/A
- P/E Ratio
- COCP N/A
- COSM N/A
- Revenue Growth
- COCP N/A
- COSM N/A
- 52 Week Low
- COCP $1.12
- COSM $0.28
- 52 Week High
- COCP $3.26
- COSM $1.58
- Technical
- Relative Strength Index (RSI)
- COCP 45.80
- COSM 45.07
- Support Level
- COCP $1.48
- COSM $0.42
- Resistance Level
- COCP $1.58
- COSM $0.47
- Average True Range (ATR)
- COCP 0.10
- COSM 0.03
- MACD
- COCP -0.01
- COSM -0.00
- Stochastic Oscillator
- COCP 15.38
- COSM 21.56
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.